Cytokinetics Statistics
NASDAQ: CYTKHealth CareBiotechnology: Pharmaceutical PreparationsUSD
61.12-0.23 (-0.37%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Cytokinetics by the numbers
Cytokinetics has a market capitalization of $8.50 billion based on 139.02M shares outstanding. With trailing EPS of $-7.19, Cytokinetics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 16.1% below its 50-day average and 12.9% below its 200-day average.
Average daily trading volume is 1.95M shares, or about $119.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CYTK valuation vs. peer median
| Metric | CYTK | Peer median | Difference |
|---|---|---|---|
| Market cap | $8.50B | $7.85B | +8% |
| Avg. volume | 1.95M | 1.50M | +30% |
Peer median across 8 companies: ARWR, TGTX, AXSM, PTGX, ABVX, SYRE, ALKS, AMRX.
Valuation
- Market cap
- $8.50B
- Price / sales (latest FY)
- 96.52
- EPS (TTM)
- $-7.19
- Shares outstanding
- 139.02M
Price and trading
- Previous close
- 61.35
- Open
- 61.09
- Day range
- 60.15 – 62.05
- 52-week range
- 54.30 – 88.31
- 52-week change
- +1.58%
- Beta
- —
- Volume
- 2.40M
- Average volume
- 1.95M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 8.50B
- Forward Pe
- -13.73
- Eps
- -7.19
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 88.31
- Week52 Low
- 54.30
- Avg Volume
- 1.95M
- Shares Outstanding
- 139.02M
- Ma50
- 72.88
- Ma200
- 70.16
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -30.79%
- Pct From52w Low
- 12.56%